Physician profile
Sridhar Neralla
NPI 1477565174
$3,179.99
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $291 · 2021: $401 · 2022: $2,080 · 2023: $137 · 2024: $39.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,507.09 | 2022 | |
| Glaxosmithkline, LLC. | $334.60 | 2019-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $230.20 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.90 | 2019-2022 | |
| Grifols USA, LLC | $144.23 | 2021-2022 | |
| Amgen INC. | $125.70 | 2022-2023 | Tezspire |
| Genentech USA, INC. | $115.40 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $93.14 | 2020-2023 | Dupixent |
| United Therapeutics Corporation | $76.84 | 2021-2023 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $68.56 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $48.05 | 2023 | Uptravi |
| Mylan Specialty L.P. | $41.38 | 2020-2022 | |
| Inari Medical, INC. | $39.93 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech, INC. | $38.00 | 2019 | |
| Insmed, INC. | $36.04 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.05 | 2021-2022 | |
| Genzyme Corporation | $32.02 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $24.76 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.77 | 2019 | |
| Ani Pharmaceuticals, INC. | $15.33 | 2023 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sridhar Neralla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.